SCHEMBL25709063

SCHEMBL25709063

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(C45C[C@H]6C[C@@H](C4)C[C@@H](C5)C6)cc3)n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.60
▸ ALDH1A1 P00352 4/20 0.55
▸ LMNA P02545 3/20 0.55
▸ TSHR P16473 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HSD11B1 P28845 1/20 0.44
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ GRIN2B Q13224 1/20 0.44
▸ GRIN2C Q14957 1/20 0.44
▸ GRIN3A Q8TCU5 1/20 0.44
▸ EPHX2 P34913 2/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ POLB P06746 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ GFER P55789 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31074776 1.00 HTT (0.60) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL25710150 0.98 HTT (0.59) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005166 0.94 HTT (0.55) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005173 0.94 HTT (0.55) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005177 0.94 HTT (0.55) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005162 0.92 HTT (0.54) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005161 0.92 HTT (0.54) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005175 0.92 HTT (0.54) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL18317438 0.92 HTT (0.54) HTTALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL31005163 0.92 HTT (0.54) HTTALDH1A1LMNATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SLC43A1, SLC7A5, L1CAM HTT 2603/4885ALDH1A1 3782/4885LMNA 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback